Hematology

THE 30ᵗʰ EUROPEAN Hematology Association (EHA) Congress was held in the beautiful city of Milan, Italy from the 12ᵗʰ–15ᵗʰ of June 2025…

Systemic light chain (AL) amyloidosis is a rare plasma cell dyscrasia characterised by the extracellular deposition of misfolded Ig light…

During the Specialized Working Group session, ‘Quality of Life and Symptoms: Promoting Connection Between Patients and Clinicians’, which…

The most important advances in Ph-negative ALL come from the incorporation of immunotherapy into first-line ALL. In this sense…

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…

My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…